Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L03 IMMUNOSTIMULANTS
L03A IMMUNOSTIMULANTS
L03AX Other immunostimulants
L03AX24 Mavorixafor
D11510 Mavorixafor (USAN) <US>
USP drug classification [BR:br08302]
Blood Products and Modifiers
Blood Products and Modifiers, Other
Mavorixafor
D11510 Mavorixafor (USAN)
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG01644 CYP2D6 substrate
D11510 Mavorixafor
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D11510 Mavorixafor
Target-based classification of drugs [BR:br08310]
Cytokines and receptors
Cytokine receptors
Chemokine receptors
CXCR4 (CD184)
D11510 Mavorixafor (USAN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D11510
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11510
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D11510